Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alan Meds vs CoreAge Rx

By GLP-1 Scorecard · Updated October 2026

On a first purchase, we would avoid committing six months just to secure a monthly equivalent. Get CoreAge's selected quote before comparing it with Alan's prepaid tirzepatide term. Alan may fit a planned longer purchase, but its renewal-processing date needs its own reminder. Neither headline establishes your first debit.

Consider Alan when the prepayment and renewal timetable suit you

Alan advertises semaglutide at $158 a month with two months paid upfront under a buy-one-get-one promotion. Tirzepatide starts at a $325 monthly equivalent with six months prepaid. These are different commitments, not verified monthly card charges. Confirm the first payment, post-promotion amount and treatment period before treating either as your budget. The terms allow the first renewal to process up to five business days early and require cancellation at least three business days before renewal processing. They separately describe three days before the next term begins. Get the actual processing date and applicable cutoff; a reminder based only on the treatment-period end could be late. Partly used subscription periods are not refundable under the stated rule. The Help page promises a full refund after clinical rejection, but makes prescription sales final and says cancellation is unavailable once medical review is submitted and processing begins. Consent more broadly says no refunds or exchanges. Resolve that difference if a rejection refund is essential. We would not commit a larger balance on the assumption that unused treatment can simply be refunded.

Read the Alan Meds review →

Compare CoreAge after settling the selected offer and refund rule

CoreAge's product pages start at $79 a month for semaglutide and $129 for tirzepatide, with no membership fee or long-term-contract advertising. Those figures are a reason to request a quote, not proof of your first charge or supplied quantity. A separate campaign qualifies its starting prices with twelve months paid in full. Do not apply that condition automatically to the product pages, or assume their offer matches the campaign. Ask for the complete term before using our six-month cost guide. CoreAge's FAQ promises no automatic rebills and a full rejection refund. The refund policy permits subscriptions and retains an applicable $50–$100 consultation fee. It makes prescription orders final after approval and pharmacy transmission; the terms also refer to completed clinical review and/or transmission. An order active more than thirty days after purchase may be treated as completed medical services even before medication ships. Resolve those differences before choosing on price; our cancellation guide separates stopping renewal from recovering a payment.

Read the CoreAge Rx review →

Get the actual preparation, usable supply, shipment schedule and assigned pharmacy for either service. Our vial-label guide explains what to request. These purchasing differences do not establish interchangeable medicines, pharmacy quality or better treatment outcomes.

Alan Meds
Site position #238

Lower grade

CoreAge Rx
Site position #1

Higher grade

Score comparison

CoreAge Rx has the higher recorded score — 89.5/100 to 65.7/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

CoreAge Rx scores 89.5/100 (B+).

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCoreAge Rx +20
72
92
Dose & formulationCoreAge Rx +13
75
88
Clinical oversightCoreAge Rx +38
55
93
Labs & monitoringCoreAge Rx +37
53
90
FulfillmentCoreAge Rx +17
78
95
Contract termsCoreAge Rx +12
55
67
Alan Meds · top barCoreAge Rx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAlan MedsCoreAge Rx
WeighScore65.7/10089.5/100
GradeCB+
Site position#238#1
Semaglutide$158/mo equivalent (2-month upfront promotion, compounded)Product page from $79/mo; navigation $99. Confirm selected quote.
Tirzepatide$325/mo equivalent (6-month upfront plan, compounded)From $129/mo advertised; confirm selected charge, supply and renewal.
CoverageEligibility depends on state, prescription and pharmacyUS only; therapy-specific state restrictions apply
Brand-name accessYesNot confirmed
Oral / sublingualYesNot confirmed
Alan Meds

Site position #238 · C

FDAWarning letter issued to Alan Health Technologies Inc. dba Alan in February 2026. See the FDA warning-letter database.

Strengths

  • Advertised compounded injection pricing stays the same across doses
  • Online care with a choice of injection and sublingual preparations
  • Outside-pharmacy choice described; separate charges may apply
  • Public catalog lists branded Wegovy and Zepbound options

What to consider

  • Lowest compounded price labels require upfront multi-month payment
  • First renewal may process early; cancel before the actual processing deadline
  • Unused subscription periods are not refundable under the ordinary terms
  • Rejection-refund promise differs from broader medical-consent wording
CoreAge Rx

Site position #1 · B+

Strengths

  • Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
  • Advertises the same price across doses and no membership fee
  • Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy

What to consider

  • Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
  • FAQ no-rebill and payment-timing statements differ from the subscription and order policy
  • FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
  • Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
  • Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard